Pharmaceutical News

RSS

Early antiretroviral therapy treatment benefits HIV-infected infants

Giving antiretroviral therapy immediately after diagnosis for a limited period of time is more beneficial than postponing treatment in young infants infected with HIV, slowing progression of the disease and delaying the time to starting long-term ART, according to new research published in The Lancet.

23 Aug 2013

Report shows nonmedical use of pain relievers may increase risk of using heroin later

A new report by the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that people aged 12 to 49 who had used prescription pain relievers nonmedically were 19 times more likely to have initiated heroin use recently (within the past 12 months of being interviewed) than others in that age group (0.39 percent versus 0.02 percent).

23 Aug 2013

Moffitt Cancer Center study could offer hope to melanoma sufferers

A new study at Moffitt Cancer Center could offer hope to people with melanoma, the deadliest form of skin cancer. Researchers are investigating whether an injectable known as PV-10 can shrink tumors and reduce the spread of cancer.

23 Aug 2013

Drug to treat blood cancers may also stop spread of invasive breast cancer

A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.

23 Aug 2013

New Pharmacological Drug Target Identified In The Brain

...

22 Aug 2013

Mount Sinai, Exosome Partner On Body Fluid Molecular Diagnostics

...

22 Aug 2013

Evotec And Jain Extend Research Collab In Skeletal Muscular Dystrophy

...

22 Aug 2013

Adimab Scores Two Deals And Some Milestone Payments

...

22 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2013-2014 season. Novartis plans to ship a minimum of 30 million doses of its influenza vaccines to the US market, including Fluvirin (Influenza Virus Vaccine), approved for use in people 4 years of age and older, and Flucelvax (Influenza Virus Vaccine), approved for use in adults 18 years of age and older.

22 Aug 2013

Drug oxytocin may contribute to postpartum bleeding, researchers find

With the number of maternal deaths on the rise in the United States, researchers found that a drug frequently used to augment or induce labor may contribute to postpartum bleeding, a study in the September issue of Anesthesiology notes.

22 Aug 2013

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

In an examination comparing the effects of two drugs on blood pressure, pulse, heart rate and cardiac output in women having elective delivery by cesarean section, an old assumption that uterine blood is redistributed into the maternal circulation after delivery was challenged, according to a study in the September issue of Anesthesiology.

22 Aug 2013

Antipsychotic drug not effective in treating delirium in critically ill patients

Haloperidol, an antipsychotic drug used in many hospitals to treat delirium in critically ill patients, is no more effective than placebo in reducing the number of days that critically ill patients spend either delirious or in a coma, according to new research published in The Lancet Respiratory Medicine.

22 Aug 2013

Pazopanib drug shows improved quality of life and safety in metastatic kidney cancer patients

Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute.

22 Aug 2013

Generic, therapeutic drug substitutions can help lower Medicare costs

Therapeutic drug substitutions have the potential to double or even triple annual cost savings compared with savings achieved with generic substitutions, according to O. Kenrik Duru and colleagues from the University of California, Los Angeles.

22 Aug 2013

Antipsychotic drugs for children with behavioral problems may put at risk for type 2 diabetes

Prescribing of "atypical" antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.

22 Aug 2013

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM).

22 Aug 2013

Pharmaceutical News

Early antiretroviral therapy treatment benefits HIV-infected infants

Report shows nonmedical use of pain relievers may increase risk of using heroin later

Moffitt Cancer Center study could offer hope to melanoma sufferers

Drug to treat blood cancers may also stop spread of invasive breast cancer

New Pharmacological Drug Target Identified In The Brain

Mount Sinai, Exosome Partner On Body Fluid Molecular Diagnostics

Evotec And Jain Extend Research Collab In Skeletal Muscular Dystrophy

Adimab Scores Two Deals And Some Milestone Payments

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Drug oxytocin may contribute to postpartum bleeding, researchers find

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

Antipsychotic drug not effective in treating delirium in critically ill patients

Pazopanib drug shows improved quality of life and safety in metastatic kidney cancer patients

Generic, therapeutic drug substitutions can help lower Medicare costs

Antipsychotic drugs for children with behavioral problems may put at risk for type 2 diabetes

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

Researchers report overall increase in use of tPA to dissolve clots blocking arteries

Scientists report possible basis for why food-restricted animals show susceptibility to drugs of abuse

New drug-delivery strategy for central vision loss

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News